Gennaro Daniele

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

Exploration of targeted anti-tumor therapy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani
Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges. International journal of molecular sciences 25 (16) (2024)
Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani
Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges. International journal of molecular sciences 25 (16) (2024)
Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Pasquale Lombardi, Marco Filetti, Rosa Falcone, Valeria Altamura, Francesco Paroni Sterbini, Emilio Bria, Alessandra Fabi, Diana Giannarelli, Giovanni Scambia, Gennaro Daniele
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings. Cancers 15 (6) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Marco Filetti, Pasquale Lombardi, Valeria Altamura, Francesco Paroni Sterbini, Giovanni Scambia, Gennaro Daniele
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers. Exploration of targeted anti-tumor therapy 4 (4) (2023)
Pasquale Lombardi, Marco Filetti, Rosa Falcone, Valeria Altamura, Francesco Paroni Sterbini, Emilio Bria, Alessandra Fabi, Diana Giannarelli, Giovanni Scambia, Gennaro Daniele
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings. Cancers 15 (6) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Simona Duranti, Antonella Pietragalla, Alessandra Fabi, Domenica Lorusso, Valeria Altamura, Francesco Paroni Sterbini, Giovanni Scambia, Gennaro Daniele
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years. Cancers 14 (4) (2022)
Camilla Nero, Simona Duranti, Flavia Giacomini, Angelo Minucci, Luciano Giacò, Alessia Piermattei, Maurizio Genuardi, Tina Pasciuto, Andrea Urbani, Gennaro Daniele, Domenica Lorusso, Raffaele Pignataro, Giampaolo Tortora, Nicola Normanno, Giovanni Scambia
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center. Journal of personalized medicine 12 (10) (2022)
Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Domenica Lorusso, Anna Fagotti, Giovanni Scambia
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert opinion on investigational drugs 30 (2) (2021)
Simona Duranti, Alessandra Fabi, Marco Filetti, Rosa Falcone, Pasquale Lombardi, Gennaro Daniele, Gianluca Franceschini, Luisa Carbognin, Antonella Palazzo, Giorgia Garganese, Ida Paris, Giovanni Scambia, Antonella Pietragalla
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers 13 (20) (2021)
Simona Duranti, Antonella Pietragalla, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Giovanni Scambia, Domenica Lorusso
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers 13 (9) (2021)
Domenica Lorusso, Valentina Ceni, Gennaro Daniele, Antonella Pietragalla, Vanda Salutari, Margherita Muratore, Camilla Nero, Francesca Ciccarone, Giovanni Scambia
Immunotherapy in gynecological cancers. Exploration of targeted anti-tumor therapy 2 (1) (2021)
Antonella Pietragalla, Francesca Ciccarone, Camilla Nero, Giovanni Scambia, Domenica Lorusso, Gennaro Daniele
Integration of PARP-inhibitors in ovarian cancer therapy. Exploration of targeted anti-tumor therapy 1 (3) (2020)